In the hush and gush of our daily lives, we have forgotten that a little act of kindness has a magnificent impact without us even noticing. Be it through helping someone, smiling back to brighten ...
Agoyu integrated its AI moving quote tool into select Realtor.com rental and for-sale listings. Users record a short video of belongings, and the AI estimates weight and volume to deliver real time ...
Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Andy Brinkmeyer shares how engineering ...
AI vulnerability scanning is moving into developer workflows. Claude Security turns findings into prioritized fix guidance. The big challenge is keeping these tools from attackers. Anthropic has ...
Sam Altman, OpenAI’s CEO and the public face of ChatGPT, has carved out an image for himself as one of the preeminent AI whisperers of our age, whose influence supposedly extends to the White House on ...
Companies are scrambling to deal with the glut. Credit...Mojo Wang Supported by By Mike Isaac and Erin Griffith Reporting from San Francisco When a financial services company recently began using ...
The publisher filed a lawsuit in Munich last week, accusing OpenAI of violating copyright laws after ChatGPT allegedly copied a popular German book series, according to The Guardian: In response to ...
Claude Code users have been flooding GitHub and Reddit over the last few days with complaints that their usage limits are being exhausted at a suspiciously fast rate, with many reporting that sessions ...
The radio signal first started broadcasting on February 28, about 12 hours after the United States and Israel began bombing Iran. On a scratchy shortwave signal almost twice a day -- in the early ...
Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...
Clinical-stage antibody company Generate:Biomedicines is the latest biotech to mull going public as momentum for IPOs continues to build. The Flagship-founded biotech has yet to set out how many ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results